Novartis Vaccines & Diagnostics, Gmbh

Rustum Boyce

Weibo Wang

Paul Andrew Barsanti

Annette Olga Walter

Kris Mendenhall

Paul A Renhowe

Hong Yang

Savithri Ramurthy

Sharadha Subramanian

David Duhl

Tinya Abrams

Eric J Martin

Liana Marie Lagniton

Ryan N Constantine

Nathan Brammeier

Megan C Phillips

Mark Knapp

Sabina Pecchi

Yi Xia

Kenneth Walter Bair

Rama Jain

Elisa Jazan

Elizabeth J Mieuli

Anu Sharma

Kelly Wayman

Vincent P Le

Kay Huh

Yia Xia

Hongyan Guo

The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: 

Substituted imidazole derivatives

The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula (I).

Indole and benzimidazole derivatives

The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds: 

Cyclized derivatives as Eg-5 inhibitors

The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula: 

Substituted imidazole compounds as KSP inhibitors

Growing community of inventors

Singapore, Singapore

Rustum Boyce